✦ LIBER ✦

PMS27 COST CONSEQUENCE ANALYSIS OF RITUXIMAB TREATMENT FOR RHEUMATOID ARTHRITIS IN ISRAEL

✍ Scribed by A Hammerman; SH Klang; N Liebermann; T Birenboim-Gal; A Shuali; M Kfir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS11 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ SF Lou; DY Chen; TT Cheng; CM Huang; HY Lin; CC Su; WC Tsai; JC Tseng; CC Wei; L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PMS31 Cost-Effectiveness Analysis of Gol

✍ R.J. Desai; J. Rao; A.K. Biddle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS70 COST-EFFECTIVENESS OF ETANERCEPT V

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS21 COST—EFFECTIVENESS OF RITUXIMAB VS

✍ LA Bynum; N Joshi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS4 COST-EFFECTIVENESS ANALYSIS OF LEFL

✍ F Carlos-Rivera; A Aguirre-Granados; SOMC Manterola 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMS28 COST-EFFECTIVNESS ANALYSIS OF NSAI

✍ V. Tolubaiev; O. Zalis'ka 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB